- Datum28.04.2025
- Uhrzeit17:00 - 18:00 Uhr
- Veranstalter
XTB
Jens Klatt
Moderator
ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001 Aktie
Verkaufen
Kaufen
ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001 Chart
ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001 Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
0,53 %
Intraday
0,03 %
1 Woche
2,65 %
1 Monat
26,23 %
Seit Jahresbeginn
15,00 %
1 Jahr
-26,06 %
3 Jahre
4.705,97 %
5 Jahre
300,00 %
10 Jahre
Passender Service zu ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001
Webinar zu ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)24,050-34,200
- Jahrestief / Hoch ($)25,400-34,200
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001
| Ex-Datum | Fiskaljahr | Dividende | Rendite |
|---|---|---|---|
| - | 2027 (e) | ||
| - | 2026 (e) | ||
| 16.05.2025 | 2026 | 0,22 $ | 0,68 % |
| 21.02.2025 | 2025 | 0,22 $ | 0,66 % |
| 15.11.2024 | 2025 | 0,21 $ | 0,82 % |
| 16.08.2024 | 2025 | 0,21 $ | 0,77 % |
| 16.05.2024 | 2025 | 0,21 $ | 0,74 % |
| 18.05.2023 | 2024 | 0,20 $ | 0,61 % |
| 15.02.2024 | 2024 | 0,21 $ | 0,72 % |
| 16.11.2023 | 2024 | 0,20 $ | 0,74 % |
| 17.08.2023 | 2024 | 0,20 $ | 0,67 % |
| 15.02.2023 | 2023 | 0,20 $ | 0,53 % |
| 17.11.2022 | 2023 | 0,19 $ | 0,45 % |
| 18.08.2022 | 2023 | 0,19 $ | 0,43 % |
| 19.05.2022 | 2023 | 0,19 $ | 0,47 % |
| 17.02.2022 | 2022 | 0,19 $ | 0,47 % |
| 18.11.2021 | 2022 | 0,17 $ | 0,40 % |
| 19.08.2021 | 2022 | 0,17 $ | 0,44 % |
| 19.05.2021 | 2022 | 0,17 $ | 0,41 % |
| 14.09.2020 | 2021 | 0,15 $ | 0,39 % |
| 18.02.2021 | 2021 | 0,17 $ | 0,36 % |
| 19.11.2020 | 2021 | 0,15 $ | 0,37 % |
Termine von ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001
- Mai8ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001Q1 2025 Earnings Release
- Aug6ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001Q2 2025 Earnings Release
Beschreibung
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
